Pharmagen Inc (PHRX)
0.00
USD |
OTCM |
Apr 25, 16:00
Pharmagen Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2014 | -0.6747 |
| December 31, 2013 | -0.5352 |
| September 30, 2013 | -0.6274 |
| June 30, 2013 | -0.6749 |
| March 31, 2013 | -0.837 |
| Date | Value |
|---|---|
| December 31, 2012 | -0.9832 |
| September 30, 2012 | -0.323 |
| June 30, 2012 | -0.6558 |
| March 31, 2012 | -0.2983 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cross Country Healthcare Inc | 0.00 |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.280M |
| Total Liabilities (Quarterly) | 9.309M |
| Shareholders Equity (Quarterly) | -8.029M |